AIDS News and Research

RSS

Sex genes of infectious fungus closely resemble human Y chromosome

Fungi and animals, including humans, have a lot in common when it comes to the arrangement of genes that determine their sex, according to new work by Howard Hughes Medical Institute geneticists at the Duke University Medical Center.

10 Nov 2004

Testosterone may impede immunity

Decreasing testosterone boosts immunity because testosterone helps control T-lymphocytes, the attack cells of the immune system, according to Mayo Clinic-led research in laboratory animals.

8 Nov 2004

Vaccine contributions to health highlighted at PAHO meeting

Vaccine programs in the Americas have made major contributions to improving health in the Americas and new vaccines could go even further, said Dr. D.A. Henderson, a global expert who chairs a Pan American Health Organization (PAHO) technical group here today.

4 Nov 2004

African American HIV patients treated by white doctors receive life-saving HIV medication later than those who have an African American doctor

"Does Racial Concordance Between HIV-Positive Patients and Their Physicians Affect the Time to Receipt of Protease Inhibitors?" is published in the November issue of the Journal of General Internal Medicine.

4 Nov 2004

Californians say yes on 71

With a clear mandate, the voters of California yesterday overwhelmingly approved Proposition 71, the California Stem Cell Research and Cures Initiative.

4 Nov 2004

Analysis of safety syringe market

One of the biggest challenges facing manufacturers of safety syringes in Europe is the lack of legislation on the use of these products in health care settings.

2 Nov 2004

Cellular enzyme represents a potential new target for developing improved HIV drugs

Scientists have discovered that a cellular enzyme helps ferry HIV genetic instructions out of the cell nucleus where they can then be translated into proteins to begin their most destructive work.

1 Nov 2004

Scientists decode the genome sequence of Cryptosporidium hominis, one of the most common causes of waterborne diseases in humans

A team of scientists at Tufts University School of Veterinary Medicine has helped decode the genome sequence of Cryptosporidium hominis, an insidious parasite identified as one of the most common causes of waterborne diseases in humans and classified by the Centers for Disease Control and Prevention as a potential bioterrorist agent.

29 Oct 2004

Is NICE delivering the goods?

Implementation of guidance issued by the National Institute for Clinical Excellence (NICE) has been mixed, according to a study in this week's BMJ.

29 Oct 2004

Training of primary care physicians helps increase referrals and cardiac rhythm management device sales

The cardiac rhythm management (CRM) market is poised for phenomenal growth with about 22 million cardiac patients worldwide and more people dying of sudden cardiac arrest than from lung/breast cancer and AIDS combined.

28 Oct 2004

New insights into hormone therapy show when estrogen best aids brain

New hormone therapy studies demonstrate estrogen's ability to directly stimulate neurons, repair damaged neurons, and stimulate support cells—most of which can alleviate some of the cognitive decline associated with menopause.

28 Oct 2004

A radical change is needed in the way TB is tackled globally

On the eve of a major international conference on tuberculosis and lung health, the humanitarian medical organisation Médecins Sans Frontières (MSF) warns that millions of individuals in developing countries continue to die from this curable disease.

26 Oct 2004

Researchers investigate new treatment options, including ways to boost immune responses to better control HIV

Highly active antiretroviral therapy (HAART) for the treatment of individuals infected by HIV-1 is limited by high costs, drug resistance, and drug-related toxicities. This has led researchers to investigate new treatment options, including ways to boost immune responses to better control HIV.

25 Oct 2004

Boehringer Ingelheim - New Drug Application (NDA) for tipranavir

The Company is seeking accelerated approval of tipranavir and has requested a priority, six-month review of the NDA. Priority review designation is based upon whether a drug provides a significant improvement in the treatment of a serious or life-threatening disease.

25 Oct 2004

Who should and who should not get a flu shot?

This year's supply of flu vaccine is limited. It is important that people at highest risk of serious illness or death from the flu get a flu shot. Complete this CDC form to see if you or your child should or should not get a flu shot.

25 Oct 2004

A new general medical journal launched this week with a non-traditional publishing model

A new general medical journal launched this week with a non-traditional publishing model is the latest top-tier venue for publishing important, peer-reviewed biomedical research, and is being called the first major, international journal to be introduced in more than 70 years.

22 Oct 2004

Home defibrillators now being sold on Amazon.com

Royal Philips Electronics has announced that the Philips HeartStart Home Defibrillator is now available over-the-counter (OTC) to consumers at Amazon.com, the largest online retailer to offer the product.

22 Oct 2004

First public healthcare and HIV/AIDS programme in Kibera, Kenya

On October 21, in collaboration with the Kenyan Ministry of Health, the international humanitarian organization Medecins Sans Frontieres (MSF) opened a health centre providing public healthcare, including treatment for HIV/AIDS, for the residents of Kibera slum in Nairobi.

22 Oct 2004

MedImmune initiates clinical trial comparing intranasal influenza vaccine with injectable flu vaccine

MedImmune announced that it has initiated a pivotal head-to-head Phase 3 clinical trial designed to compare its next-generation, refrigerator- stable intranasal influenza vaccine (CAIV-T: cold adapted intranasal influenza vaccine, trivalent) with the injectable flu shot (TIV: trivalent influenza vaccine).

22 Oct 2004

Research findings will likely aid efforts to develop a vaccine for Leishmania major

Researchers at Washington University School of Medicine in St. Louis and the University of Pennsylvania have found an immune system cell can "remember" a parasite's attack and help the body mount a more effective defense against subsequent invasions by the same parasite.

21 Oct 2004

AIDS News and Research

Sex genes of infectious fungus closely resemble human Y chromosome

Testosterone may impede immunity

Vaccine contributions to health highlighted at PAHO meeting

African American HIV patients treated by white doctors receive life-saving HIV medication later than those who have an African American doctor

Californians say yes on 71

Analysis of safety syringe market

Cellular enzyme represents a potential new target for developing improved HIV drugs

Scientists decode the genome sequence of Cryptosporidium hominis, one of the most common causes of waterborne diseases in humans

Is NICE delivering the goods?

Training of primary care physicians helps increase referrals and cardiac rhythm management device sales

New insights into hormone therapy show when estrogen best aids brain

A radical change is needed in the way TB is tackled globally

Researchers investigate new treatment options, including ways to boost immune responses to better control HIV

Boehringer Ingelheim - New Drug Application (NDA) for tipranavir

Who should and who should not get a flu shot?

A new general medical journal launched this week with a non-traditional publishing model

Home defibrillators now being sold on Amazon.com

First public healthcare and HIV/AIDS programme in Kibera, Kenya

MedImmune initiates clinical trial comparing intranasal influenza vaccine with injectable flu vaccine

Research findings will likely aid efforts to develop a vaccine for Leishmania major

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Latest News